1412 Cardiology,
ครบ 1 ปีพอดี จากกิจกรรมครั้งแรกของเพจเราที่ CoLab Convent ใน Liberty…
ครบ 1 ปีพอดี จากกิจกรรมครั้งแรกของเพจเราที่ CoLab Convent ใน Liberty…
Rendez-Vous de…
Rendez-Vous de…
น้องทั้ง 10 คนที่ได้รับคัดเลือกจากผู้สมัครทั้งหมด 936 คน Congratulation, you are cordially invited to join us for 1412…
DRAMS is hosting Cardiology Journal Club soon! Here are the details: 27th Nov (Wed) 1-2pm (Flexible Teaching Area) As usual…
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
Interesante adición al manejo del paciente post IAM! http://www.nejm.org/doi/full/10.1056/NEJMoa1410489#article
平成27年度第4回薬剤師のジャーナルクラブ開催のお知らせ 開催日時:平成27年7月26日(日曜日) ■午後20時45分頃 仮配信 ■午後21時00分頃 本配信 なお配信時間は90分を予定しております. ※ツイキャス配信はこちらから→http://twit…
Original Article from The New England Journal of Medicine — Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Journal club 2015/06/24 病棟の抄読会です。 スタチンで悪玉コレステロール(LDL-C)を下げれば、心筋梗塞などの虚血性心疾患の発症を抑制できますが、新しいコレステロール低下薬のエゼチミブ(ゼチーア)でLDL-Cをさらに下げるとどうな…
Ezetimiba y estatinas en el sindrome coronario…
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes http://t.co/L35yypTktC
"@NEJM: Original Article: Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. http://t.co/4nOKItMM8v" #cardiology
IMPROVE-IT: lowering LDL cholesterol to levels below previous targets provided additional benefit http://www.nejm.org/doi/full/10…
When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular…
Bizim televizyonlardaki sağlık programları statinlerin (kolesterol düşürücü ilaçlar) olumsuz etkilerini tartışadursun; her geçen…
หลังจาก IMPROVE-IT ตีพิมพ์ลงใน New England Journal of…
#nhs #revalidation #appraisal Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes http://www.nejm.org/doi/full/10.10…
http://www.nejm.org/doi/full/10.1056/NEJMoa1410489?query=TOC
NEJM: Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes http://t.co/Qa90zASVTa
Retweeted Eric Topol (@EricTopol): A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people)
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
IMPROVE-IT Summary .....
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
https://www.facebook.com/TheNewEnglandJournalofMedicine/videos/vb.92777318461/10153106461313462/?type=2
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
Retweeted NEJM (@NEJM): When added to statin, does drug that lowers intestinal cholesterol absorption reduce CV events even…
ΕΖΕΤΙΜΙΜΠΗ+ΣΤΑΤΙΝΗ ΜΕΤΑ ΑΠΟ ΚΑΡΔΙΑΓΓΕΙΑΚΟ ΣΥΜΒΑΜΑ... Ενδιαφέρον άρθρο μολονότι όχι παιδιατρικό... Ezetimibe Added to Statin…
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
IMPROVE-IT finally published
View the new Quick Take on the IMPROVE-IT study on ezetimibe and cardiovascular outcomes. http://nej.md/1MhyHIs
In a randomized trial, 18,144 patients within 10 days of an acute coronary syndrome were randomly assigned to simvastatin 40 mg…
In a randomized trial, 18,144 patients within 10 days of an acute coronary syndrome were randomly assigned to simvastatin 40 mg…
IMPROVE-IT finally published looking at zetia on top of statin in those with heart disease. http://www.nejm.org/doi/full/10.1056…
Publicado ayer: Resultados del IMPROVE IT, ezetimibe em sindrome coronario agudo. NEJM. http://www.nejm.org/doi/full/10.1056/N…
Publicado ayer: Resultados del IMPROVE IT, ezetimibe em sindrome coronario agudo. NEJM. http://www.nejm.org/doi/full/10.1056/N…
Ezetimibe (понижава интестиналната абсорбция на холестерол), добавен към симвастатин при пациенти след остър коронарен синдром по…
Original Article from The New England Journal of Medicine — Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Publicado en NEJM el estudio IMPROVE-IT. Bajar el colesterol LDL a 50 mg/dl mejor que 70 mg/dl en prevención secundaria de…
In a randomized trial, 18,144 patients within 10 days of an acute coronary syndrome were randomly assigned to simvastatin 40 mg…
In a randomized trial, 18,144 patients within 10 days of an acute coronary syndrome were randomly assigned to simvastatin 40 mg…
อ่านรายงานการศึกษาฉบับนี้แล้วเห็นว่าอย่างไรกันครับ ต่อจากนี้ไปเราจะต้องใช้ยาลดไขมันตัวใหม่นี้เพิ่มไปกับ simvastatin ที่มีอยู่เดิม…
Retweeted NEJM (@NEJM): Watch new Quick Take on IMPROVE-IT study on ezetimibe and CV outcomes. What you need to know, in < 2…
Retweeted Eric Topol (@EricTopol): A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people)
Retweeted NEJM (@NEJM): IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV…
In a randomized trial, 18,144 patients within 10 days of an acute coronary syndrome were randomly assigned to simvastatin 40 mg…